|
| Press Releases |
|
 |
|
| Monday, August 16, 2021 |
|
|
EC Healthcare Acquires Veterinary Hospital Chain |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group enters into a sales and purchase agreement to acquire the entire issued share capital of a veterinary hospital chain (the "Target Companies") and the total consideration will be paid in cash. more info >> |
|
| Thursday, July 29, 2021 |
|
|
医思健康与Prenetics建立战略合作伙伴关系 引领医学未来 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团与Prenetics Limited（「Prenetics」）就拟建立战略合作伙伴关系签署谅解备忘录 more info >> |
|
|
醫思健康與Prenetics建立戰略合作夥伴關係 引領醫學未來 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團與Prenetics Limited（「Prenetics」）就擬建立戰略合作夥伴關係簽署諒解備忘錄 more info >> |
|
|
EC Healthcare and Prenetics Form Strategic Partnership to Pioneer the Future of Medicine |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Prenetics Limited ("Prenetics") for a strategic collaboration in relation to the formation of a "Healthnomics collaboration". more info >> |
|
| Tuesday, July 27, 2021 |
|
|
医思健康公布季度销售数据 成功拓展新旗舰服务中心 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，为满足对医疗及健康服务的殷切需求，本集团于2021年7月26日扩展其位于旺角朗豪坊办公大楼的旗舰服务中心，新租用了额外一楼层, 其总楼面面积约为17,900平方呎。 more info >> |
|
|
醫思健康公佈季度銷售數據 成功拓展新旗艦服務中心 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，為滿足對醫療及健康服務的殷切需求，本集團於2021年7月26日擴展其位於旺角朗豪坊辦公大樓的旗艦服務中心，新租用了額外一樓層, 其總樓面面積約為17,900平方呎。 more info >> |
|
|
EC Healthcare Announced Quarterly Sales Volume, Successfully Expanded New Flagship Service Centre |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that, to fulfill the strong demand for medical and healthcare services, on 26 July 2021 more info >> |
|
| Friday, July 9, 2021 |
|
|
医思健康进一步向策略性股东郑志刚博士及 Aspex Management 发行股份 加强医疗地产化战略部署 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，策略性投资者郑志刚博士及Aspex Management以先旧后新方式进一步增持集团股权，加强双方战略关系及促进集团的发展。 more info >> |
|
|
醫思健康進一步向策略性股東鄭志剛博士及 Aspex Management 發行股份 加強醫療地產化戰略部署 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，策略性投資者鄭志剛博士及Aspex Management以先舊後新方式進一步增持集團股權，加強雙方戰略關係及促進集團的發展。 more info >> |
|
|
EC Healthcare Further Issue Shares to Strategic Shareholder Dr. Cheng Chi Kong and Aspex Management To Enhance Collaboration in Deploying Medical Real Estate Strategy |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group's strategic shareholders Dr. Cheng Chi Kong and Aspex Management further increase equity stake in the Group via Top-up Placing, further enhancing the strategic relationship and empowering the Group's development. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
珠宝双展匯聚逾82,000环球买家
Mar 9, 2025 13:51 HKT/SGT
|
|
|
珠寶雙展匯聚逾82,000環球買家
Mar 9, 2025 13:41 HKT/SGT
|
|
|
Twin jewellery shows attract over 82,000 global buyers
Mar 9, 2025 13:19 HKT/SGT
|
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million
Mar 8, 2025 19:40 HKT/SGT
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 8, 2025 19:20 HKT/SGT
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 21:26: JST
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 7, 2025 20:31: JST
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 20:26 HKT/SGT
|
|
|
雲頂新耀股價創3年新高 AI+mRNA賦能管線重塑估值
Mar 7, 2025 19:24 HKT/SGT
|
|
|
云顶新耀股价创3年新高 AI+mRNA赋能管线重塑估值
Mar 7, 2025 19:16 HKT/SGT
|
|
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙
Mar 7, 2025 18:28 HKT/SGT
|
|
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙
Mar 7, 2025 18:10 HKT/SGT
|
|
|
東信營銷科技：中國AI營銷龍頭斬獲多模態雙備案 技術實力獲國家級認證
Mar 7, 2025 17:58 HKT/SGT
|
|
|
东信营销科技：中国AI营销龙头斩获多模态双备案 技术实力获国家级认证
Mar 7, 2025 17:20 HKT/SGT
|
|
|
Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels
Mar 7, 2025 16:24 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
